SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-160033
Filing Date
2024-06-12
Accepted
2024-06-12 17:08:00
Documents
13
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d851376d8k.htm   iXBRL 8-K 28668
  Complete submission text file 0001193125-24-160033.txt   154567

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmea-20240612.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20240612_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20240612_pre.xml EX-101.PRE 11718
16 EXTRACTED XBRL INSTANCE DOCUMENT d851376d8k_htm.xml XML 3741
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 241039200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)